Biotech & Pharma

First-in-Human Stem Cell Therapy Trial for Huntington's Disease Begins at UCI Health

22 sec read1 views0 listens

UCI Health has initiated the world's first in-human clinical trial using embryonic stem cell-derived neural stem cells to treat Huntington’s disease. This pioneering therapy, if successful, could significantly extend independent living for patients and reduce long-term care costs, offering hope to those with few treatment options.

Read the full article at Genetic Engineering News

Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision

Apnimed has appointed Kevin Lin as its new CEO as the company moves towards the potential commercialization of its investigational oral therapy for obstructive sleep apnea. This leadership transition is critical for developers and tech professionals ...

Ali Nemati

Legal & Policy2 days ago33 sec read

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

A Pennsylvania federal court rejected federal preemption as a defense to terminating a medical marijuana cardholder, holding that Pennsylvania's state protections survive despite federal prohibition and that zero-tolerance policies inadequately addre...

Ali Nemati

Cybersecurity3 days ago29 sec read

AI scribes promise relief for clinicians yet Canada's experience shows the trade-offs are real

AI-powered medical scribes are being piloted in Canada to automate clinical note generation from patient-clinician conversations, aiming to reduce administrative burdens and clinician burnout. While offering efficiency gains, these tools raise concer...

Ali Nemati

Biotech & PharmaJun 1728 sec read

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

Merck has partnered with Protillion Biosciences to accelerate drug discovery through a collaboration potentially worth up to $510 million. This initiative leverages Protillion's AI-driven "lab-in-the-loop" platform, combining extensive wet-lab data w...

Ali Nemati

Biotech & PharmaJun 1524 sec read

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs

ZoBio has launched a comprehensive DNA-Encoded Library (DEL) discovery service to aid in the identification of drug targets that are difficult or novel. This integrated platform combines multiple techniques, including protein production, biophysical ...

Ali Nemati

First-in-Human Stem Cell Therapy Trial for Huntington's Disease Begins at UCI Health

Related Articles

Apnimed Appoints New CEO as Investigational OSA Therapy Nears FDA Decision

Fired a Medical Marijuana User After a Drug Test? A Pennsylvania Court Says Not So Fast.

AI scribes promise relief for clinicians yet Canada's experience shows the trade-offs are real

Merck, Protillion Launch AI Drug Discovery Collaboration with Up-to-$510M in Milestone Payments

ZoBio Introduces DNA-Encoded Library Service for Exploratory Drug Discovery Programs